<DOC>
	<DOC>NCT00681213</DOC>
	<brief_summary>Comparison of outcomes/safety/and tolerability of SRL/FK/Pred vs. FK/MMF/Pred vs. SRL/NeoralÂ®/Pred in cadaveric and non-HLA identical LRD kidney transplants.</brief_summary>
	<brief_title>Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Age &gt;14 years Weight &gt; 40 kg Primary renal allograft: cadaveric or mismatched living donor Negative standard cross match for Tcells Women of childbearing potential will be required to have a negative qualitative serum pregnancy test and agree to use an adequate method of contraception throughout the study period and for 3 months after discontinuation of study medication (3yrs, 3 mos.) Signed and dated informed consent (Parent or legal guardian must provide written consent for patients &lt;18 years of age) Evidence of systemic infection History of malignancy within 10 years (with the exception of localized skin cancer) Use of any investigational drug or treatment up to 4 weeks prior to enrolling in the study and during the 12month treatment phase Concurrent use of astemizole, pimozide, cisapride, terfenadine, or ketoconazole Known hypersensitivity to sirolimus and its derivatives Patients with a screening/baseline (or within 96 hours of transplant) total white blood cell count &lt; 4000/mm3; platelet count &lt; 100,000/mm3; fasting triglycerides &gt; 400 mg/dl (&gt; 4.6 mmol/L); fasting total cholesterol &gt; 300 mg/dl (&gt; 7.8 mmol/L); fasting HDLcholesterol &lt; 30 mg/dl; fasting LDLcholesterol &gt; 200mg/dl</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>